Assembly Biosciences (ASMB)
(Delayed Data from NSDQ)
$12.65 USD
-0.71 (-5.31%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $12.39 -0.26 (-2.06%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth B Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | -2.74 |
EPS Last Quarter | NA |
Last EPS Surprise | NA |
ABR | 2.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -12.65 |
Next Year | -13.45 |
EPS (TTM) | -17.05 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | 7.16M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -2.74 | -2.96 | -12.65 | -13.45 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -2.74 | -2.96 | -12.65 | -13.45 |
High Estimate | -2.74 | -2.96 | -12.65 | -13.45 |
Low Estimate | -2.74 | -2.96 | -12.65 | -13.45 |
Year ago EPS | -4.44 | -3.84 | -13.38 | -12.65 |
Year over Year Growth Est. | 38.29% | 22.92% | 5.46% | -6.32% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -2.74 | -2.96 | -12.65 | -13.45 |
7 Days Ago | -2.74 | -2.96 | -12.65 | -13.45 |
30 Days Ago | NA | NA | -14.77 | -13.57 |
60 Days Ago | -3.24 | -3.48 | -14.77 | -13.57 |
90 Days Ago | -3.24 | -3.48 | -14.77 | -13.57 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -2.74 | -2.96 | -12.65 | -13.45 |
Zacks Consensus Estimate | -2.74 | -2.96 | -12.65 | -13.45 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | NA | -3.24 | -3.84 | -4.44 | NA |
Estimate | NA | -2.76 | -3.48 | -4.44 | NA |
Difference | NA | -0.48 | -0.36 | 0.00 | -0.28 |
Surprise | NA | -17.39% | -10.34% | 0.00% | -9.24% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more